BNTX
BioNTech SENASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage limited
Factor tilt: Value-tilted Large Cap
$89.01-7.13%
Close Oct 13, 2026
- Market cap
- $22.55B
- 1 month
- -10.0%
- 3 months
- -3.2%
- 1 year
- -12.8%
- 52-week range
- $83.89$119.34
- Dividend
- No payments on record
- Short interest
- 2.3% of float2.5M shares · settled Sep 30, 2026 · +7.5% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if BNTX is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
57 top institutions tracked
as of 2026-Q2 (filed 2026-09-22)
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: bearish
Last trade: sell 5 days ago
Red flags: 0
Largest 13-F holders · Q2 2026
283 filers reported a long position in BNTX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $704.6M | 7.6M | +32.6% |
| PRIMECAP MANAGEMENT CO/CA/ | $351M | 3.8M | -0.6% |
| DODGE & COX | $342.2M | 3.7M | 0% |
| FLOSSBACH VON STORCH SE | $207.1M | 2.2M | -39.5% |
| T. Rowe Price Investment Management, Inc. | $192.2M | 2.1M | -64.7% |
| BlackRock, Inc. | $172.6M | 1.9M | +11.9% |
| Temasek Holdings (Private) Ltd | $140.1M | 1.5M | Unchanged |
| BNP PARIBAS FINANCIAL MARKETS | $122.8M | 1.3M | -20.1% |
| Logos Global Management LP | $94.4M | 1M | New |
| GSK plc | $82.8M | 889.8K | Unchanged |
Get the Full Analysis for BNTX
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.